Baxter International Inc. (BAX) To Go Ex-Dividend on November 28th

Baxter International Inc. (NYSE:BAX) announced a quarterly dividend on Tuesday, November 11th. Stockholders of record on Friday, November 28th will be paid a dividend of 0.01 per share by the medical instruments supplier on Friday, January 2nd. This represents a c) dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 28th.

Baxter International has increased its dividend by an average of 0.0%per year over the last three years. Baxter International has a dividend payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Baxter International to earn $2.73 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 1.5%.

Baxter International Trading Up 2.7%

Baxter International stock opened at $18.66 on Wednesday. The stock has a 50-day simple moving average of $21.07 and a 200 day simple moving average of $25.40. The stock has a market capitalization of $9.59 billion, a P/E ratio of -62.21, a PEG ratio of 0.73 and a beta of 0.57. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.49 and a current ratio of 2.30. Baxter International has a 52 week low of $17.40 and a 52 week high of $37.74.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.60 by $0.09. Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.The company had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.88 billion. During the same period last year, the firm posted $0.80 earnings per share. The business’s revenue was up 5.0% on a year-over-year basis. Baxter International has set its Q4 2025 guidance at 0.520-0.570 EPS. FY 2025 guidance at 2.350-2.400 EPS. Analysts expect that Baxter International will post 2.48 earnings per share for the current year.

Institutional Trading of Baxter International

Institutional investors have recently modified their holdings of the stock. Arkadios Wealth Advisors bought a new position in shares of Baxter International in the first quarter worth $590,000. OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in Baxter International during the first quarter worth about $246,000. Argent Trust Co acquired a new stake in Baxter International during the first quarter worth about $201,000. Raiffeisen Bank International AG increased its holdings in Baxter International by 24.9% in the 1st quarter. Raiffeisen Bank International AG now owns 95,668 shares of the medical instruments supplier’s stock valued at $3,229,000 after buying an additional 19,081 shares during the period. Finally, Nicholas Hoffman & Company LLC. raised its position in shares of Baxter International by 2.0% in the 1st quarter. Nicholas Hoffman & Company LLC. now owns 31,739 shares of the medical instruments supplier’s stock valued at $1,086,000 after buying an additional 636 shares in the last quarter. 90.19% of the stock is currently owned by institutional investors.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.